Investigating the role of immunotherapy for real-world patients with HER2-negative advanced gastric cancer between 2011 and 2023

Background: Although the emergence of immunotherapy has benefited patients with advanced gastric cancer (AGC), the magnitude of the benefit among real-world patients with HER2-negative AGC remains unclear. Objectives: The current study aimed to evaluate the treatment features across various immunoth...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Keitaro Shimozaki, Akira Ooki, Koichiro Yoshino, Mikako Tamba, Shohei Udagawa, Hiroki Osumi, Shota Fukuoka, Izuma Nakayama, Takeru Wakatsuki, Mariko Ogura, Daisuke Takahari, Eiji Shinozaki, Keisho Chin, Kensei Yamaguchi
Format:	Artigo
Jezik:	Inglês
Izdano:	SAGE Publishing 2025-02-01
Serija:	Therapeutic Advances in Medical Oncology
Online dostop:	https://doi.org/10.1177/17588359251322670
Oznake:	Označite Brez oznak, prvi označite!